Montag & Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.32K Hold
554
﹤0.01% 813
2025
Q4
$3.97K Hold
554
﹤0.01% 829
2025
Q3
$5.92K Hold
554
﹤0.01% 808
2025
Q2
$5.36K Sell
554
-20
-3% -$206 ﹤0.01% 796
2025
Q1
$8.55K Sell
574
-213
-27% -$3.28K ﹤0.01% 802
2024
Q4
$11.7K Sell
787
-309
-28% -$5.04K ﹤0.01% 771
2024
Q3
$21K Buy
1,096
+7
+0.6% +$145 ﹤0.01% 724
2024
Q2
$22.5K Hold
1,089
﹤0.01% 694
2024
Q1
$20.5K Sell
1,089
-127
-10% -$2.18K ﹤0.01% 694
2023
Q4
$17.5K Sell
1,216
-90
-7% -$1.22K ﹤0.01% 707
2023
Q3
$22.7K Sell
1,306
-573
-30% -$11.9K ﹤0.01% 656
2023
Q2
$39.1K Buy
1,879
+81
+5% +$1.76K ﹤0.01% 604
2023
Q1
$42.3K Sell
1,798
-3,416
-66% -$91.7K ﹤0.01% 587
2022
Q4
$146K Sell
5,214
-280
-5% -$7.16K 0.01% 412
2022
Q3
$129K Sell
5,494
-199
-3% -$6.01K 0.01% 416
2022
Q2
$192K Sell
5,693
-913
-14% -$32K 0.01% 368
2022
Q1
$231K Sell
6,606
-1,952
-23% -$66.8K 0.01% 374
2021
Q4
$261K Sell
8,558
-3,888
-31% -$127K 0.01% 364
2021
Q3
$408K Sell
12,446
-4,153
-25% -$133K 0.02% 311
2021
Q2
$502K Buy
+16,599
New +$546K 0.03% 298

Other funds holding OGN

Montag & Associates's OGN Position: Q1 2026 in Review

Montag & Associates held its Organon & Co (OGN) position steady in Q1 2026 at 554 shares worth $3.32K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

Montag & Associates first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $502K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Montag & Associates held 554 shares of Organon & Co worth $3.32K as of Q1 2026.
  • Montag & Associates left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #813 holding.
  • Montag & Associates first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Montag & Associates's Organon & Co position peaked at $502K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.